company · 1 story across the archive · newest first · biotech
mentions by month
mixed HN readers were intrigued by the imaging milestone and the possibility of cheaper, more portable brain vascular imaging, but the discussion was heavily skeptical about the company’s bigger claims. Commenters focused on safety, the need for validation against MRI or other imaging, and whether the microbubble-based super — latest discussion,